Lumira Capital Investment Management Inc.

Insider Reports History

Location
Toronto, Ontario, Canada
Signature
/s/ Vasco Larcina, CFO of Lumira Capital Investment Management Inc.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lumira Capital Investment Management Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
enGene Holdings Inc. 10%+ Owner Common Shares 1,341,790 $13,417,900 $10.00 20 Feb 2024 Held by Lumira Ventures III, L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 1,077,386 $10,773,860 $10.00 20 Feb 2024 Held by Merck Lumira Biosciences Fund, L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 993,651 $9,936,510 $10.00 20 Feb 2024 Held by Lumira Ventures IV, L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 238,851 $2,388,510 $10.00 20 Feb 2024 Held by Lumira Ventures IV (International), L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 152,974 $1,529,740 $10.00 20 Feb 2024 Held by Merck Lumira Biosciences Fund (Quebec), L.P.
enGene Holdings Inc. 10%+ Owner Common Shares 44,647 $446,470 $10.00 20 Feb 2024 Held by Lumira Ventures III (International), L.P.

Insider Reports Filed by Lumira Capital Investment Management Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENGN enGene Holdings Inc. 20 Feb 2024 2 +$8,000,000 4 10%+ Owner 21 Feb 2024, 16:20
ENGN enGene Holdings Inc. 31 Oct 2023 0 $0 3 10%+ Owner 07 Nov 2023, 18:08